Bromfenac sodium and Amaryl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bromfenac sodium (bromfenac sodium) and Amaryl (glimepiride). Common drug interactions include abscess limb among females and loss of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Bromfenac sodium and Amaryl. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Bromfenac sodium?

Bromfenac sodium has active ingredients of bromfenac sodium. eHealthMe is studying from 356 Bromfenac sodium users. Check the latest studies of Bromfenac sodium.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.



On Jul, 12, 2026

11 people who take Bromfenac sodium and Amaryl together, and have interactions are studied.

Bromfenac sodium and Amaryl drug interactions.

What are the common drug interactions of Bromfenac Sodium and Amaryl, by gender? *:

female:

  1. Abscess limb (limb infection)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Upper respiratory tract inflammation
  4. Cardiac failure
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Lung disorder (lung disease)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Perinephric abscess
  9. Septic shock (shock due to blood infection)
  10. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)

male:

  1. Loss of consciousness
  2. Subdural haematoma (blood collects between the skull and the surface of the brain)
  3. Lacunar infarction (a type of stroke)
  4. Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
  5. Decreased appetite
  6. Dizziness
  7. Headache (pain in head)
  8. Vomiting
  9. Dysarthria (speech disorder)
  10. Dyslalia (inability to articulate comprehensible speech)

What are the common drug interactions of Bromfenac Sodium and Amaryl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abscess limb (limb infection)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Loss of consciousness
  4. Subdural haematoma (blood collects between the skull and the surface of the brain)
  5. Upper respiratory tract inflammation
  6. Decreased appetite
  7. Dizziness
  8. Headache (pain in head)
  9. Hyphaema (collection of blood inside the front part of the eye)
  10. Intraocular pressure increased

60+:

  1. Abscess limb (limb infection)
  2. Arthritis fungal (inflammation of a joint by a fungus)
  3. Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
  4. Upper respiratory tract inflammation
  5. Arthropathy
  6. Femur fracture
  7. Joint injury
  8. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  9. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  10. Tooth disorder (tooth disease)

What are the existing conditions these people have? *

  1. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 7 people, 63.64%
  2. High Blood Pressure: 5 people, 45.45%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 36.36%
  4. Osteoporosis (bones weak and more likely to break): 3 people, 27.27%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 27.27%
  6. Depression: 3 people, 27.27%
  7. Oedema (fluid collection in tissue): 2 people, 18.18%
  8. Herpes Simplex Ophthalmic (eye infection is caused by a type of herpes simplex virus): 2 people, 18.18%
  9. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 18.18%
  10. Cataract (clouding of the lens inside the eye): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Bromfenac sodium and Amaryl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bromfenac sodium and Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bromfenac sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bromfenac sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amaryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bromfenac sodium and glimepiride (the active ingredients of Bromfenac sodium and Amaryl, respectively), and Bromfenac sodium and Amaryl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: